High ductal proportion predicts biochemical recurrence in prostatic ductal adenocarcinoma

BJU Int. 2019 Dec;124(6):907-909. doi: 10.1111/bju.14831. Epub 2019 Sep 6.

Authors

Timothy Harkin^{1

2

3}, Oussama Elhage^{2

3}, Ashish Chandra⁴, Nawal Khan², Yusuf Kiberu², Mark Frydenberg¹, Prokar Dasgupta^{2

3}

Affiliations

¹ Department of Surgery, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
² The Urology Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
³ MRC Centre for Transplantation, NIHR Biomedical Research Centre, King's Health Partners, Guy's Hospital, London, UK.
⁴ Department of Histopathology, Guy's and St Thomas' NHS Foundation Trust,, London, UK.

PMID: 31136054
DOI: 10.1111/bju.14831

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Ductal* / mortality
Carcinoma, Ductal* / pathology
Carcinoma, Ductal* / surgery
Cohort Studies
Humans
Male
Prostate / pathology
Prostate / surgery
Prostatectomy
Prostatic Neoplasms* / mortality
Prostatic Neoplasms* / pathology
Prostatic Neoplasms* / surgery
Recurrence